Drug class
Mucolytics
Mucolytics are a therapeutic class of mucoactive drugs formulated to decrease the viscosity and elasticity of thick respiratory tract secretions. Read more about Mucolytics
7 drugs in this class 7 manufacturers
Drugs in Mucolytics
ACETYLCYSTEINE
ACETYLCYSTEINE
ACETYLCYSTEINE
ACETYLCYSTEINE
ACETYLCYSTEINE
ACETYLCYSTEINE
Mucolytics are a therapeutic class of mucoactive drugs formulated to decrease the viscosity and elasticity of thick respiratory tract secretions.
They function primarily by enzymatically cleaving extracellular DNA polymers or chemically cleaving disulfide bonds within mucin glycoproteins, thereby liquefying mucus to facilitate mucociliary clearance and expectoration.
Clinically, these agents are utilized to manage hypersecretory airway diseases and mucus plugging associated with conditions such as cystic fibrosis, chronic obstructive pulmonary disease, and bronchiectasis.
-
clevelandclinic.org
Mucolytics are a therapeutic class of mucoactive drugs formulated to decrease the viscosity and elasticity of thick respiratory tract secretions
-
nih.gov
Mucolytics are a therapeutic class of mucoactive drugs formulated to decrease the viscosity and elasticity of thick respiratory tract secretions
-
nih.gov
They function primarily by enzymatically cleaving extracellular DNA polymers or chemically cleaving disulfide bonds within mucin glycoproteins, thereby liquefying mucus to facilitate mucociliary clearance and expectoration
-
nih.gov
They function primarily by enzymatically cleaving extracellular DNA polymers or chemically cleaving disulfide bonds within mucin glycoproteins, thereby liquefying mucus to facilitate mucociliary clearance and expectoration
-
nih.gov
They function primarily by enzymatically cleaving extracellular DNA polymers or chemically cleaving disulfide bonds within mucin glycoproteins, thereby liquefying mucus to facilitate mucociliary clearance and expectoration
-
nih.gov
Clinically, these agents are utilized to manage hypersecretory airway diseases and mucus plugging associated with conditions such as cystic fibrosis, chronic obstructive pulmonary disease, and bronchiectasis
-
nih.gov
Clinically, these agents are utilized to manage hypersecretory airway diseases and mucus plugging associated with conditions such as cystic fibrosis, chronic obstructive pulmonary disease, and bronchiectasis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.